Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma

The long-term survival of Hodgkin lymphoma (HL) patients treated according to the current standard of care is excellent. Combined-modality schedules (ABVD plus radiotherapy) in early-stage disease, along with treatment intensity adaptation to early metabolic response assessed by PET/CT in advanced s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassilakopoulos, Theodoros P., Liaskas, Athanasios, Pereyra, Patricio, Panayiotidis, Panayiotis, Angelopoulou, Maria K., Gallamini, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487754/
https://www.ncbi.nlm.nih.gov/pubmed/37685994
http://dx.doi.org/10.3390/ijms241713187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487754/
https://www.ncbi.nlm.nih.gov/pubmed/37685994
http://dx.doi.org/10.3390/ijms241713187

Ejemplares similares